全文获取类型
收费全文 | 195788篇 |
免费 | 2021篇 |
国内免费 | 107篇 |
专业分类
耳鼻咽喉 | 1476篇 |
儿科学 | 6905篇 |
妇产科学 | 3223篇 |
基础医学 | 18859篇 |
口腔科学 | 1981篇 |
临床医学 | 13606篇 |
内科学 | 36053篇 |
皮肤病学 | 993篇 |
神经病学 | 18403篇 |
特种医学 | 9700篇 |
外科学 | 32217篇 |
综合类 | 2423篇 |
预防医学 | 18823篇 |
眼科学 | 3143篇 |
药学 | 10967篇 |
中国医学 | 669篇 |
肿瘤学 | 18475篇 |
出版年
2023年 | 114篇 |
2022年 | 236篇 |
2021年 | 424篇 |
2020年 | 216篇 |
2019年 | 315篇 |
2018年 | 22237篇 |
2017年 | 17632篇 |
2016年 | 19796篇 |
2015年 | 1268篇 |
2014年 | 1284篇 |
2013年 | 1402篇 |
2012年 | 7862篇 |
2011年 | 21992篇 |
2010年 | 19351篇 |
2009年 | 12015篇 |
2008年 | 20395篇 |
2007年 | 22651篇 |
2006年 | 1621篇 |
2005年 | 3276篇 |
2004年 | 4419篇 |
2003年 | 5348篇 |
2002年 | 3523篇 |
2001年 | 1012篇 |
2000年 | 1212篇 |
1999年 | 837篇 |
1998年 | 486篇 |
1997年 | 458篇 |
1996年 | 312篇 |
1995年 | 270篇 |
1994年 | 246篇 |
1993年 | 197篇 |
1992年 | 448篇 |
1991年 | 464篇 |
1990年 | 464篇 |
1989年 | 456篇 |
1988年 | 407篇 |
1987年 | 345篇 |
1986年 | 300篇 |
1985年 | 310篇 |
1984年 | 227篇 |
1983年 | 193篇 |
1982年 | 111篇 |
1980年 | 110篇 |
1979年 | 139篇 |
1978年 | 111篇 |
1974年 | 115篇 |
1973年 | 88篇 |
1972年 | 84篇 |
1970年 | 85篇 |
1969年 | 101篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
Kazunori Aizawa Takeshi Hanaoka Hiroki Kasai Kaoru Kogashi Setsuo Kumazaki Jun Koyama Hiroshi Tsutsui Yoshikazu Yazaki Noboru Watanabe Osamu Kinoshita Uichi Ikeda 《Hypertension research》2006,29(2):123-128
The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more potent and selective PDE-5 inhibitor than sildenafil, has been approved for the treatment of erectile dysfunction. However, the long-term effects of oral vardenafil in patients with PH are unknown. We studied five consecutive patients with PH; one with primary pulmonary hypertension, two with chronic pulmonary thromboembolism, one with Eisenmenger syndrome (ventricular septal defect) and one with secondary pulmonary hypertension after a ventricular septal defect closure operation. In an acute hemodynamic trial, vardenafil (5 mg) significantly decreased both the pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) with an increase in cardiac output. In a chronic hemodynamic trial, the maintenance dose of vardenafil (10 to 15 mg) for 3 months significantly decreased the PVR, but not the SVR, with a 20.7% reduction of the PVR/ SVR ratio. Plasma brain natriuretic peptide (BNP) levels were also significantly decreased after 3 months. This pilot study demonstrates that long-term oral vardenafil therapy may be a safe and effective treatment for patients with PH. 相似文献
23.
24.
25.
26.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
27.
28.
29.
30.
Ichiro Yasuda Takuji Iwashita Takaya Ohnishi Tsuyoshi Mukai Masamichi Enya Eiichi Tomita Hisataka Moriwaki 《Digestive endoscopy》2006,18(Z1):S92-S95
Endoscopic nasobiliary drainage (ENBD) is a well established mode of biliary decompression. Although ENBD is certainly an uncomfortable procedure with the potential risk of spontaneous dislocation or removal of the drainage catheter by disoriented patients, it has several advantages over endoscopic biliary drainage (EBD) using an indwelling stent. The current indications for ENBD are: (i) temporary drainage to treat obstructive jaundice and cholangitis caused by malignant or benign biliary stricture; (ii) urgent drainage to treat suppurative cholangitis primarily caused by common bile duct stones; (iii) temporary drainage after stone removal in patients with suspected incomplete clearance and/or with cholangitis; and (iv) biliary leaks that occur primarily after surgery, as well as other indications. Different types of nasobiliary catheters are currently available that have been designed with various diameters, shapes, and materials. However, the current catheters are not considered by most endoscopists to be sufficient. Further improvements are needed to achieve better drainage and better maneuverability. 相似文献